Stocks and Investing Stocks and Investing
Thu, December 8, 2022
Wed, December 7, 2022
Tue, December 6, 2022
Mon, December 5, 2022

Geoff Meacham Maintained (ABBV) at Hold with Increased Target to $162 on, Dec 5th, 2022


Published on 2024-10-28 00:26:06 - WOPRAI, Geoff Meacham
  Print publication without navigation


Geoff Meacham of B of A Securities, Maintained "AbbVie Inc." (ABBV) at Hold with Increased Target from $160 to $162 on, Dec 5th, 2022.

Geoff has made no other calls on ABBV in the last 4 months.



There are 10 other peers that have a rating on ABBV. Out of the 10 peers that are also analyzing ABBV, 4 agree with Geoff's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Justin Smith of "Societe Generale" Downgraded from Strong Buy to Hold on, Tuesday, November 8th, 2022
  • Navin Jacob of "UBS" Maintained at Hold with Increased Target to $147 on, Monday, October 31st, 2022
  • Steve Chesney of "Atlantic Equities" Maintained at Hold with Decreased Target to $157 on, Monday, October 31st, 2022
  • Carter Gould of "Barclays" Maintained at Hold with Decreased Target to $155 on, Monday, October 31st, 2022


These are the ratings of the 6 analyists that currently disagree with Geoff


  • Trung Huynh of "Credit Suisse" Initiated at Buy and Held Target at $170 on, Friday, November 18th, 2022
  • Matthew Harrison of "Morgan Stanley" Maintained at Buy with Decreased Target to $178 on, Monday, October 31st, 2022
  • Gary Nachman of "BMO Capital" Maintained at Buy with Decreased Target to $169 on, Monday, October 31st, 2022
  • David Risinger of "SVB Leerink" Maintained at Sell with Decreased Target to $135 on, Friday, September 30th, 2022
  • Terence Flynn of "Morgan Stanley" Reiterated at Buy and Held Target at $188 on, Wednesday, September 14th, 2022
  • Jasper Hellweg of "Argus Research" Maintained at Strong Buy with Decreased Target to $155 on, Wednesday, August 24th, 2022